Summit Therapeutics (SMMT) Other Gross PP&E Adjustments: 2018-2025
Historic Other Gross PP&E Adjustments for Summit Therapeutics (SMMT) over the last 6 years, with Sep 2025 value amounting to -$5.4 million.
- Summit Therapeutics' Other Gross PP&E Adjustments rose 32.05% to -$5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$37.1 million, marking a year-over-year decrease of 6.58%. This contributed to the annual value of -$19.8 million for FY2024, which is 126.21% down from last year.
- According to the latest figures from Q3 2025, Summit Therapeutics' Other Gross PP&E Adjustments is -$5.4 million, which was up 2.38% from -$5.6 million recorded in Q2 2025.
- In the past 5 years, Summit Therapeutics' Other Gross PP&E Adjustments ranged from a high of -$1.5 million in Q1 2021 and a low of -$19.8 million during Q4 2024.
- In the last 3 years, Summit Therapeutics' Other Gross PP&E Adjustments had a median value of -$7.0 million in 2023 and averaged -$8.1 million.
- As far as peak fluctuations go, Summit Therapeutics' Other Gross PP&E Adjustments tumbled by 2,821.80% in 2021, and later skyrocketed by 36.30% in 2025.
- Summit Therapeutics' Other Gross PP&E Adjustments (Quarterly) stood at -$3.6 million in 2021, then plummeted by 61.63% to -$5.9 million in 2022, then tumbled by 49.39% to -$8.7 million in 2023, then plummeted by 126.21% to -$19.8 million in 2024, then soared by 32.05% to -$5.4 million in 2025.
- Its last three reported values are -$5.4 million in Q3 2025, -$5.6 million for Q2 2025, and -$6.4 million during Q1 2025.